<DOC>
	<DOCNO>NCT02553382</DOCNO>
	<brief_summary>Despite availability multiple medication treatment Type 2 diabetes , patient often continue difficulty attain blood glucose target manage cardiovascular disease risk factor . Recent trend non-pharmacological therapy create grow public interest dietary supplement . Research group others support benefit whole grain , viscous dietary fibre ginseng management diabetes . The current study investigate whether co-administration viscous dietary fibre blend , Salba ( grain rich omega-3 fatty acid ) , 2 variety ginseng root improve blood sugar control cardiovascular disease risk outcomes individual Type 2 diabetes already receive conventional treatment . Patients Type 2 diabetes receive recommend intervention accordance Canadian Diabetes Association guideline enrol 6-month clinical study . Half participant randomly assign 4-component intervention comprise co-administration four dietary/herbal supplement addition usual treatment regimen ; half continue usual treatment regimen addition take high-oat fiber wheat bran supplement . The investigator hypothesize intensified , multi-targeted intervention addition dietary herb component improve long-term blood glucose control cardiovascular disease risk factor beyond conventional therapy . If combination viscous fiber , Salba ginseng show beneficial , remedy could complement current conventional therapy Type 2 diabetes goal improve health outcome .</brief_summary>
	<brief_title>Fibre Grain Herb Trial Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes medically diagnose least 6months prior randomization HbA1c ( glycated hemoglobin ) 6.3 % 8.5 % screen BMI &lt; 35 kg/m2 Insulin therapy Blood pressure â‰¥ 160/100 mmHg Serum triglyceride &gt; 4.5mmol/L History major cardiovascular event ( stroke myocardial infarction ) Gastrointestinal , liver kidney disease Consumption alcohol &gt; 2 drinks/day Current tobacco smoker Taking following medication : herb supplement may affect primary secondary outcome , monoamine oxidase inhibitor ( MAOIs ) antidepressants and/or anticoagulant therapy Women hormone sensitive tumors/conditions</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>